N-terminal pro-brain natriuretic peptide and resistance to chronic therapy with 75 mg acetylsalicylic acid assessed by point-of-care test - prospective single center study.
2 September 2019 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Bieganski Hospital, Lodz (Poland)
7 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:00 CET
